Gesynta Pharma has dosed the first patient in its Phase II trial, NOVA, investigating vipoglanstat, a non-hormonal, ...

EAU 2026: Preliminary Results of a Phase II Study to Evaluate the Efficacy and Safety of Disitamab Vedotin (RC48-ADC) in Combination with Radiotherapy for Adjuvant Therapy in Upper Tract Urothelial ...

Biomea Fusion BMEA shares closed up on Friday as the company is presenting positive data from its Phase II COVALENT-111 study ...

Q4 2025 Management View Leiv Lea, Chief Financial Officer, reported research and development expenses of $9.9 million in Q4 2025, attributing the increase to higher clinical trial and manufacturing ...

US-based biopharmaceutical company Spinogenix has concluded the enrolment of patients in its Phase II clinical trial of tazbentetol (previously known as SPG302), a synaptic regenerative treatment for ...

Centessa Pharmaceuticals (NASDAQ:CNTA) used remarks at a healthcare conference to highlight recent progress in its orexin ...

FDA authorization under an IND permits first-in-human phase I/II testing of SVT-001 in familial drusen, focusing on safety ...

NanoViricides (NYSE-A:NNVC) said on Wednesday it has completed manufacturing of its NV-387 oral drug product, clearing a key step toward dosing patients in an upcoming clinical trial for mpox. The ...

Residents in portions of North Florida, including Duval County, are being asked to conserve water after the St. Johns River ...